Company / Debt per Share
AYTU BIOPHARMA, INC Debt per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.82
FY2025
5-year range
$0.55 / $7.78
FY2022-FY2025
Trend
-7.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $7.78 to $1.82 over the past 2 years.
Based on SEC 10-K filings.
1.82 in FY2025 with a 3-year CAGR of +49.5%.
Improved from $7.78 to $1.82 over the past 2 years.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +49.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, debt per share decreased 7.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.82 | -7.5% |
| FY2024 | $1.97 | -74.6% |
| FY2023 | $7.78 | +1325.2% |
| FY2022 | $0.55 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026